Conference Poster
Year : 2019
Geneviève Michel : Connect in order to contact the contributor
https://hal.univ-brest.fr/hal-02151122
Submitted on : Friday, June 7, 2019-4:59:02 PM
Last modification on : Wednesday, January 17, 2024-9:52:07 AM
Dates and versions
Identifiers
- HAL Id : hal-02151122 , version 1
Cite
Alain Saraux, Thomas Barnetche, Guy Baudens, Isabelle Idier, Flore Delaporte, et al.. Subcutaneous tocilizumab in monotherapy or in combination with csdmard in patients with moderate to severe rheumatoid arthritis: observational study to describe real-world drug retention rate at 12 months.. EULAR 2019, Jun 2019, MADRID, Spain. ⟨hal-02151122⟩
Collections
28
View
0
Download